CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
20 May, 2026, 04.22 PM IST
Hantavirus scare: Evacuations planned as suspected outbreak traps 150 on ship off Cape VerdeMedics are working to evacuate two individuals with hantavirus symptoms from a luxury cruise ship off West Africa after an outbreak claimed...
05 May, 2026, 07.01 AM IST
ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
27 Apr, 2026, 08.52 AM IST
Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
24 Apr, 2026, 08.17 AM IST
Bayer challenges IPAB’s compulsory licence order to Natco Pharma on cancer drug Nexavar“We introduce the product after years of research and investment, while companies like Natco merely copy and manufacture the product,” said...
12 Oct, 2013, 04.01 AM IST
Pharma companies should have clear rules for business in India: GermanyBahr advocating stronger cooperation between Indian and Germany in the health sector, especially in immigration of medical and nursing prof...
29 Apr, 2013, 10.08 PM IST
- Bayer says it will defend its intellectual property rights on cancer drug
Bayer today said it will continue to defend its IP rights while expressing disappointment at the IPAB decision to reject the firm's plea to...
17 Sep, 2012, 08.19 PM IST
- Bayer demands withdrawal of Natco Pharma's compulsory licence
In March, India allowed Natco Pharma to legally make and sell a low-cost version of cancer drug Nexavar at 3% of the original medicine's pr...
19 May, 2012, 01.47 AM IST
- Bayer challenges Nexavar generic licence order
Bayer has filed an appeal against a patents order, which allowed domestic drug maker Natco Pharma to sell a generic version of the German f...
07 May, 2012, 05.08 PM IST
- Germany's Fresenius recalls India-made drugs shipped to US
German drug co recalled two batches of cancer drug made by its Indian arm on cross-contamination.
04 Oct, 2010, 05.58 AM IST
- Cipla makes cancer drug cheaper
Cipla has launched a copycat version of German pharma company Bayer’s cancer medicine Nexavar at one-tenth the price.
09 Apr, 2010, 02.53 AM IST
- HC rejects Bayer plea on Nexavar copycat
The Delhi HC dismissed an appeal by German drugmaker Bayer that sought to stop Cipla from obtaining a marketing approval from the country’s...
10 Feb, 2010, 02.16 AM IST
- Pharma cos recast European operations to protect margins
Indian pharmaceutical companies are reworking their strategies for Europe to cope with the intense pressure on drug prices because of chang...
08 May, 2009, 04.07 AM IST
- DRL, Ranbaxy, Wockhardt vie for German mega-deal
The bid is scheduled to open in the first week of November. Germany, which is the world’s second largest drug market, looks for ways to cur...
14 Oct, 2008, 12.00 AM IST
- Dr Reddy's could face margin pressure in Germany
Leading Indian drug makers with a large presence in Germany could face substantial pressure on margins following a recent tender by a Germa...
13 Oct, 2008, 07.16 PM IST
- DRL bets on India plan for German arm
Dr Reddy’s Laboratories (DRL) aims to shift production of about a dozen top-selling products of its German arm Betapharm to India by July 2...
24 Dec, 2007, 04.31 AM IST
- German govt ruling forces generics cos to cut prices
Last month, the German government announced its decision to change rules to induce drugmakers to charge less for their products.
05 Jun, 2006, 12.00 AM IST